Cell & Gene Therapy
Contract Development and Manufacturing Organisation (CDMO)
Product Development, Launch & Supply
Enabling healthcare companies to launch and supply products
Cell & Gene Therapy | Pharmaceutical | Biotechnology | Medical Device
Your Commercialisation Journey
HiTech Health is delighted to partner with VascVersa, a regenerative medicine company developing exciting new cell therapies that promote vascular regeneration and repair. VascVersa is a spin-out of Queen's University Belfast and built on over 20 years of research....
The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under Ireland’s National Development Plan (NDP) in 2018. On Thursday 23rd November, Ireland’s Minister for Enterprise, Trade and Employment, Simon Coveney TD, Minister for Further...
Hitech Health is delighted to be attending Advanced Therapies Integrates in Stevenage, England on the 30th November. This event aims to drive the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies,...
Stay Up To Date
Connect with us to receive the latest HiTech Health and industry updates.